  | Ludwig-Begall, L., Wielick, C., Jolois, O., Dams, L., Razafimahefa, R. M., Nauwynck, H., Demeuldre, P.-F., NAPP, A., Laperre, J., Thiry, E., & Haubruge, E. (2021). "Don, doff, discard" to "don, doff, decontaminate" FFR and mask integrity and inactivation of a SARS-CoV-2 surrogate and a norovirus following multiple vaporised hydrogen peroxide-, ultraviolet germicidal irradiation-, and dry heat decontamination. PLoS ONE. doi:10.1371/journal.pone.0251872  Peer Reviewed verified by ORBi |
 | Wielick, C., Ludwig-Begall, L., Dams, L., Razafimahefa, R. M., Demeuldre, P.-F., NAPP, A., Laperre, J., Haubruge, E., & Thiry, E. (2021). The use of germicidal ultraviolet light, vaporised hydrogen peroxide and dry heat to decontaminate face masks and filtering respirators contaminated with an infectious norovirus. Infection Prevention in Practice, 3, 100111. doi:10.1016/j.infpip.2020.100111 Peer Reviewed verified by ORBi |
 | Ludwig-Begall, L., Wielick, C., Dams, L., Nauwynck, H., Demeuldre, P.-F., Napp, A., Laperre, J., Haubruge, E., & Thiry, E. (2020). The use of germicidal ultraviolet light, vaporised hydrogen peroxide and dry heat to decontaminate face masks and filtering respirators contaminated with a SARS-CoV-2 surrogate virus. Journal of Hospital Infection, 106, 577-584. doi:10.1016/j.jhin.2020.08.025 Peer Reviewed verified by ORBi |
 | Demelenne, A., NAPP, A., Bouillenne, F., Crommen, J., Servais, A.-C., & Fillet, M. (2019). Insulin aggregation assessment by capillary gel electrophoresis without sodium dodecyl sulfate: Comparison with size-exclusion chromatography. Talanta, 199, 457-463. doi:10.1016/j.talanta.2019.02.074 Peer Reviewed verified by ORBi |
 | Sambon, M., NAPP, A., Demelenne, A., Vignisse, J., Wins, P., Fillet, M., & Bettendorff, L. (2019). Thiamine and benfotiamine protect neuroblastoma cells against paraquat and ß- amyloid toxicity by a coenzyme-independent mechanism. Heliyon, 5, 01710. doi:10.1016/j.heliyon.2019.e01710 Peer Reviewed verified by ORBi |
Demelenne, A., Napp, A., Radermecker, R., Servais, A.-C., & Fillet, M. (19 December 2018). Quality control and aggregation follow-up of insulin formulations [Paper presentation]. First CIRM scientific day, Liège, Belgium. |
 | Demelenne, A., Napp, A., Servais, A.-C., & Fillet, M. (10 September 2018). Insulin aggregation assessment by size-exclusion chromatography and capillary gel electrophoresis [Poster presentation]. the 11th International Symposium on Drug Analysis and the 29th International Symposium on Pharmaceutical and Biomedical Analysis. |
Demelenne, A., NAPP, A., Servais, A.-C., & Fillet, M. (12 July 2018). Follow-up of Insulin Aggregation productions in the context of formulation quality control [Poster presentation]. Second international symposium on advanced in Pharmaceutical analysis, Lilles, France. |
  | Napp, A., Houbart, V., Demelenne, A., Merville, M.-P., Crommen, J., Dumoulin, M., Garraux, G., Servais, A.-C., & Fillet, M. (2018). Separation and determination of alpha-synuclein monomeric and oligomeric species using two electrophoretic approaches. Electrophoresis, 39 (23), 3022-3031. doi:10.1002/elps.201800224 Peer Reviewed verified by ORBi |
 | Napp, A., Houbart, V., Demelenne, A., Servais, A.-C., & Fillet, M. (18 September 2017). Challenges in the determination of amyloid oligomeric species by two electrophoretic techniques [Poster presentation]. CE-PHARM 2017, Boston, United States. |
 | Demelenne, A., Napp, A., Lamalle, C., Servais, A.-C., & Fillet, M. (21 June 2017). Quality control of insulin formulations: API , protamine and aggregates follow-up [Poster presentation]. The 45th International Symposium on High Performance Liquid Phase Separations and Related Techniques (HPLC), Prague, Czechia. |
Demelenne, A., Napp, A., Servais, A.-C., & Fillet, M. (October 2016). Study of insulin aggregation by SEC and CGE [Paper presentation]. 19th Forum of Pharmaceutical Sciences, Bruxelles, Belgium. |
Napp, A., Houbart, V., Servais, A.-C., Merville, M.-P., Garraux, G., & Fillet, M. (19 May 2016). Analytical Challenges for the determination of alpha-synuclein and its oligomeric forms in the context of parkinson disease [Paper presentation]. Séminaire du CIRM. |
Houbart, V., Napp, A., Rudaz, S., Schappler, J., & Fillet, M. (April 2016). Alpha-synuclein as biomarker in Parkinson’s disease: strategies for detection in CGE-LIF [Paper presentation]. 32nd International Symposium on Microscale Separations and Bioanalysis (MSB 2016), Niagara-on-the-lake, Canada. |
Houbart, V., Napp, A., Rudaz, S., Schappler, J., & Fillet, M. (April 2016). Alpha-synuclein as biomarker in Parkinson’s disease: strategies for detection in CGE-LIF [Poster presentation]. 32nd International Symposium on Microscale Separations and Bioanalysis (MSB 2016), Niagara-on-the-lake, Canada. |
 | Houbart, V., COBRAIVILLE, G., Servais, A.-C., Napp, A., Merville, M.-P., & Fillet, M. (2015). Hepcidin determination in dried blood by microfluidic LC-MS/MS: comparison of DBS and volumetric absorptive microsampling for matrix effect and recovery. Bioanalysis, 7 (21), 2789-99. doi:10.4155/bio.15.181 Peer Reviewed verified by ORBi |
 | Napp, A., Garraux, G., Servais, A.-C., Merville, M.-P., & Fillet, M. (June 2014). EVALUATION OF α-SYNUCLEIN AS BIOMARKER OF PARKINSON'S DISEASE [Poster presentation]. 10th International Symposium on Drug Analysis. |
| Napp, A., Garraux, G., Servais, A.-C., Merville, M.-P., & Fillet, M. (17 October 2013). EVALUATION OF α-SYNUCLEIN AS BIOMARKER OF PARKINSON'S DISEASE [Paper presentation]. 17th Forum of Pharmaceutical Sciences, Spa, Belgium. |
Napp, A., & Fillet, M. (23 May 2013). Les biomarqueurs de la maladie de Parkinson [Paper presentation]. Séminaire du Centre Interfacultaire de Recherche du Médicament (C.I.R.M), Liege, Belgium. |